07:49 AM EST, 12/11/2024 (MT Newswires) -- Q32 Bio ( QTTB ) shares slumped 65% pre-bell Wednesday after the company said late Tuesday its phase 2a trial of a treatment candidate for atopic dermatitis failed to meet its primary endpoint.
ImmunityBio ( IBRX ) dropped 27% after the company priced a $100 million stock offering.
Comstock (CHCI) shares were down 18% after a 2.2% loss Tuesday.